RT @bsutariya: @advocatehealth & @Cerner continues to lead innovation in #Readmission prediction with latest publication https://t.co/ThEan…
@advocatehealth & @Cerner se posicionan como líderes en la prevención de recaídas a 30 días gracias a la #HCE https://t.co/Kxv1OCMXMk
RT @bsutariya: @advocatehealth & @Cerner continues to lead innovation in #Readmission prediction with latest publication https://t.co/ThEan…
RT @bsutariya: @advocatehealth & @Cerner continues to lead innovation in #Readmission prediction with latest publication https://t.co/ThEan…
RT @bsutariya: @advocatehealth & @Cerner continues to lead innovation in #Readmission prediction with latest publication https://t.co/ThEan…
RT @bsutariya: @advocatehealth & @Cerner continues to lead innovation in #Readmission prediction with latest publication https://t.co/ThEan…
RT @bsutariya: @advocatehealth & @Cerner continues to lead innovation in #Readmission prediction with latest publication https://t.co/ThEan…
RT @bsutariya: @advocatehealth & @Cerner continues to lead innovation in #Readmission prediction with latest publication https://t.co/ThEan…
RT @bsutariya: @advocatehealth & @Cerner continues to lead innovation in #Readmission prediction with latest publication https://t.co/ThEan…
@advocatehealth & @Cerner continues to lead innovation in #Readmission prediction with latest publication https://t.co/ThEanU0Woh
Nice paper comparing predictive modeling approaches for 30-day readmission risk https://t.co/kUtmjTYqHP
Comparison of predictive modeling approaches for 30-day all-cause non-elective… https://t.co/K7gxya84uF #leukemia https://t.co/2yO4MHh5CX